ADPT
Adaptive Biotechnologies Corp
3월 13일 4:00 PM ET (한국 3/14 05:00)
$13.17
+0.72 ▲ +5.78%
🌙 3월 13일 6:56 PM ET (한국 3/14 07:56)
$13.24
+0.07 ▲ +0.53%
| Index | RUT | P/E | - | EPS (ttm) | -0.4 | Insider Own | 3.62% | Shs Outstand | 0.15B | Perf Week | -11.37% |
| Market Cap | 2.03B | Forward P/E | - | EPS next Y | 45.13% | Insider Trans | -39.97% | Shs Float | 0.15B | Perf Month | -15.69% |
| Enterprise Value | 2.02B | PEG | - | EPS next Q | -0.16 | Inst Own | 97.49% | Short Float | 5.98% | Perf Quarter | -16.33% |
| Income | -0.06B | P/S | 7.32 | EPS this Y | -24.2% | Inst Trans | 4.67% | Short Ratio | 4.39 | Perf Half Y | -2.37% |
| Sales | 0.28B | P/B | 9.26 | EPS next 5Y | 47.95% | ROA | -7.92% | Short Interest | 8.88M | Perf YTD | -18.9% |
| Book/sh | 1.42 | P/C | 8.93 | EPS past 3/5Y | 34.64% 18.85% | ROE | -28.23% | 52W High | -36.56% ($20.76) | Perf Year | 83.68% |
| Cash/sh | 1.47 | P/FCF | - | Sales past 3/5Y | 14.34% 23% | ROIC | -14.32% | 52W Low | 97.3% ($6.68) | Perf 3Y | 58.67% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 63.63% | Gross Margin | 70.03% | Volatility(W/M) | 7.68% 5.59% | Perf 5Y | -68.26% |
| Dividend TTM | - | EV/Sales | 7.28 | Sales Y/Y TTM | 54.77% | Oper. Margin | -20.62% | ATR (14) | 1 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.23 | EPS Q/Q | 61.13% | Profit Margin | -21.48% | RSI (14) | 31.86 | Recom | 1.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.34 | Sales Q/Q | 51.04% | SMA20 | -14.43% ($15.39) | Beta | 2.35 | Target Price | $20.86 |
| Payout | - | Debt/Eq | 0.96 | Earnings | 2000000 | SMA50 | -20.3% ($16.52) | Rel Volume | 1.93 | Prev Close | $12.45 |
| Employees | 624 | LT Debt/Eq | 0.9 | EPS/Sales Surpr. | 51.48% 17.72% | SMA200 | -8.35% ($14.37) | Avg Volume(3M) | 2.02M | Price | $13.17 |
| IPO | 2019/6/27 | Option/Short | Yes/Yes | Trades | 21399 | Volume | 3,902,533 | Change | 5.78% |
뉴스 로딩 중...